Iradimed Corp. (IRMD) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IRMD Hot Sheet
Join SI Premium – FREE
Iradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $6 million versus the consensus estimate of $6.09 million.
For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c; Offers Guidance
- Waters Corp. (WAT) Tops Q3 EPS by 10c ; Offers Guidance
- i-80 Gold Corp. (IAUX) Misses Q3 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
